Maligned non-steroidal anti-inflammatory drugs: Misunderstanding of their safety profile in patients with renal insufficiency
Bruce M Rothschild, Department of Medicine, Indiana University, Ball Memorial Hospital, Muncie, IN 47304, United States
Author contributions: Rothschild BM conceived the study and drafted the manuscript; author approved the final version of the article.
Conflict-of-interest statement: The author has no conflict of interest to declare.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Bruce M Rothschild, MD, Professor, Department of Medicine, Indiana University, Ball Memorial Hospital, Muncie, IN 47304, United States. email@example.com
Received: May 17, 2018
Peer-review started: May 18, 2018
First decision: June 14, 2018
Revised: November 15, 2018
Accepted: November 29, 2018
Article in press: November 29, 2018
Published online: December 11, 2018